The global Western Blotting Market in terms of revenue was estimated to be worth $1.0 billion in 2021 and is poised to reach $1.4 billion by 2026, growing at a CAGR of 6.7% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Technological advancements, increasing government funding in the field of biomedical research, growing demand for personalized medicine, and the rising prevalence of HIV are the key factors driving the market growth.

Download a FREE Sample Report PDF of the Global Western Blotting Market Research Report at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235810711&utm_source=Ganesh&utm_medium=P

Key Market Players:

The western blotting market is dominated by a few globally established players such as Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Techne Corporation (US), and Merck KGaA (Germany) are the prominent players operating in the market.

The study categorizes the western blotting market to forecast revenue and analyze trends in each of the following submarkets:

By Product

• Consumables
• Reagents & Buffers
• Antibodies & Conjugates
• Primary Antibodies
• Secondary Antibodies
• Other Antibodies & Conjugates
• Kits
• Membranes & Filter Papers
• Other Consumables
• Instruments
• Electrophoresis Instruments
• Blotting Systems
• Semi-dry Blotting Systems
• Wet Blotting Systems
• Imagers
• Chemiluminescent Imagers
• Fluorescent Imagers
• Other Imagers

By Application

• Biomedical Research
• Clinical Diagnostics
• HIV
• Lyme Disease
• Hepatitis
• Other Diseases
• Agricultural Applications
• Other Applications

By End User

• Academic & Research Institutes
• Biopharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Other End Users

By Region

• North America
• US
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Rest of Asia Pacific
• Latin America
• The Middle East and Africa

By product segment, the consumables segment accounted for the largest share of the western blotting market.

Based on products, the market is segmented into instruments and consumables. Consumables commanded the major share of the western blotting products market. The large share of this product segment can primarily be attributed to the repeated use of consumables in the western blotting process and the use of reagents in large volumes.

By end user, the academic & research institutes segment accounted for the largest share of the western blotting market.

Based on end users, the market is segmented into academic & research institutes, biopharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, and other end users Academic & research institutes accounted for the largest share of the global market. The large share of the academic & research institutes end-user segment can be attributed to growing government investments for research activities and increasing research in the area of proteomics.

Direct Purchase of the Global Western Blotting Market Research Report at https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=235810711&utm_source=Ganesh&utm_medium=P

By application, the biomedical research segment accounted for the largest share of the western blotting market.

Based on applications, the global market is segmented into biomedical research, clinical diagnostics, agricultural applications, and other applications. The biomedical research application segment accounted for the largest share of this market. The large share of this segment can be attributed to the increasing research funding for proteomics and protein-based research and increasing research activities by end users such as biopharma & biotech companies.

North America accounted for the largest share of the western blotting market.

North America accounted for the largest share of the global market. The major factors driving the growth of this regional market include the presence of top manufacturers of western blotting products in this region, rise in research funding, increasing investments in proteomics research, and growing focus on personalized medicine.